New Delhi, Oct 1 (PTI) Drug firm Aurobindo Pharma on Friday said N Govindarajan has tendered his resignation as the managing director and a director on the company's board due to personal reasons.

"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the services of the company effective from the close of business on December 31, 2021," Aurobindo Pharma said in a regulatory filing.

Also Read | UGC NET December 2020, June 2021 Rescheduled, Check Revised Schedule Here.

The board has also taken note of the appointment of S Damodharan as chief operating officer for the active pharmaceutical ingredient (API) vertical, it added.

"The board has further taken note of the appointment of P Yugandhar as the chief executive officer of Eugia Pharma Specialities Ltd, a wholly-owned subsidiary of the company focused on generic injectables and oncology business," Aurobindo Pharma said.

Also Read | UPSC CDS II Result 2020 Released, Candidates Can Check Their Results Online at upsc.gov.in.

Shares of Aurobindo Pharma on Friday closed at Rs 717.25 per scrip on the BSE, down 1.21 per cent from its previous close. HRS hrs

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)